Prof. Ahmed elhenawy | Medicinal Chemistry |Best Researcher Award

Prof. Ahmed elhenawy | Medicinal Chemistry | Best Researcher Award

Prof. Ahmed elhenawy, Azhar unveristy, Egypt

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is a distinguished Egyptian chemist, born on December 23, 1978, in Hellwan, Egypt. With an h-index of 22 and 126 publications, he is a prominent figure in organic chemistry, particularly in peptide synthesis and drug development. Currently, he serves as an Assistant Professor at Albaha University, KSA, and as a Professor at Al-Azhar University, Egypt. With extensive teaching experience, he has guided numerous undergraduate and postgraduate students in organic chemistry. His contributions to research and academia reflect a commitment to advancing knowledge in chemical sciences, emphasizing innovative approaches to synthesizing biologically active compounds.

Professional Profile:

Google Scholar

Orcid

Summary of Suitability for Award:

Prof. Ahmed Abd El-Emonam El-Said El-Henawy is an exemplary candidate for the “Best Researcher Awards,” primarily due to his substantial contributions to the field of organic chemistry and his commitment to advancing scientific knowledge. With an h-index of 22 and 126 publications, his research output demonstrates a high level of impact and relevance within the academic community. His specialization in peptide synthesis, particularly the development of novel amino acid derivatives with potential antimicrobial and anticancer activities, showcases his innovative approach to addressing critical health challenges.

🎓Education:

Prof. El-Henawy completed his Bachelor’s degree in Special Chemistry at Al-Azhar University in 2000. He pursued a Master’s degree in Organic Chemistry, focusing on amino acids and proteins, graduating in 2005. His doctoral research, completed in 2008, investigated new amino acid derivatives with expected biological activities. He has held various academic positions at Al-Azhar University, including Demonstrator, Assistant Lecturer, Lecturer, Associate Professor, and Professor, contributing to the department’s growth and the education of future chemists. Additionally, he has been involved in teaching at Albaha University since 2012, where he continues to inspire students through comprehensive organic chemistry courses.

🏢Work Experience:

Prof. El-Henawy has over two decades of experience in academia and research. He began his career as a Demonstrator at Al-Azhar University in 2002 and progressed to the role of Assistant Lecturer in 2005. He became a Lecturer in 2008, then an Associate Professor in 2014, and is currently a Professor. His research focuses on the synthesis of dipeptides and related compounds with potential antimicrobial and anticancer activities. He has developed expertise in various laboratory techniques, including multistep synthesis, chromatographic purification, and spectroscopic analysis. Prof. El-Henawy has supervised numerous M.Sc. and Ph.D. theses in peptide synthesis, reflecting his dedication to nurturing the next generation of chemists. His collaborative research has been presented at international conferences and published in reputable journals.

🏅Awards:

Prof. El-Henawy has received recognition for his contributions to the field of chemistry and education. His research has led to significant advancements in organic chemistry, particularly in synthesizing biologically active compounds. While specific awards are not listed, his h-index of 22 and 126 publications highlight his impact and credibility within the scientific community. His involvement in international conferences showcases his commitment to sharing knowledge and fostering collaboration among researchers. By mentoring students and guiding their research endeavors, he has played a vital role in shaping future chemists. Prof. El-Henawy’s dedication to teaching and research has earned him respect among colleagues and students alike, establishing him as a key figure in the chemistry department at both Al-Azhar University and Albaha University

🔬Research Focus:

Prof. El-Henawy’s research primarily focuses on organic chemistry, emphasizing peptide synthesis and the development of novel amino acid derivatives. His work includes synthesizing dipeptides, tri-, tetra-, and pentapeptides with antimicrobial properties. He has also explored new sulfonamide derivatives as potential antimicrobial agents and synthesized 2-amino-1,3,4-thiadiazole derivatives with anticancer potential. His research incorporates advanced laboratory techniques, such as multistep synthesis and chromatographic isolation. Prof. El-Henawy utilizes various spectroscopic methods to elucidate the structures of synthesized compounds, contributing to the understanding of their biological activities. His commitment to pharmacological research is evident in projects funded by Albaha University, focusing on the pharmacokinetics and toxicodynamics of pharmaceutical compounds. Through his innovative research, Prof. El-Henawy aims to discover new therapeutic agents that address critical health challenges.

Publication Top Notes:

  • Title: Exploring the anti-diabetic activity of benzimidazole containing Schiff base derivatives: In vitro α-amylase, α-glucosidase inhibitions and in silico studies
  • Title: Synthesis of novel thiazole derivatives containing 3-methylthiophene carbaldehyde as potent anti α-glucosidase agents: In vitro evaluation, molecular docking, dynamics, MM-GBSA …
  • Title: Experimental and computational profiling of novel bis-Schiff base derivatives bearing α-naphthalene moiety as potential tyrosinase inhibitors
  • Title: Flurbiprofen clubbed schiff’s base derivatives as potent anticancer agents: In Vitro and In Silico approach towards breast cancer
  • Title: Synthesis, anticancer, α-glucosidase inhibition, molecular docking and dynamics studies of hydrazone-Schiff bases bearing polyhydroquinoline scaffold: In vitro and in silico

 

 

 

Prof. Hendrik G Kruge | Pharmaceutical Chemistry | Best Researcher Award

Prof. Hendrik G Kruge | Pharmaceutical Chemistry | Best Researcher Award

Prof. Hendrik G Kruge , University of KwaZulu-Natal , South Africa

Prof. Hendrik Gerhardus Kruger is a distinguished Research Professor in Health Sciences at the University of KwaZulu-Natal, South Africa. With a specialization in organic chemistry, molecular modeling, and drug design, he has significantly impacted the scientific community. Holding a PhD in Chemistry from Potchefstroom University, he has published over 400 research papers and has mentored more than 100 postgraduate students and 30 postdoctoral fellows. Kruger is recognized for his contributions to curriculum development and his service to the scientific community. As a Fellow of the South African Chemical Institute, he has played a vital role in advancing research initiatives in the region. His innovative approach to rational drug design has positioned him among the leading scientists on the African continent, dedicated to addressing critical health challenges through cutting-edge research.

Professional Profile:

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Prof. Hendrik Gerhardus Kruger is an exemplary candidate for the “Best Researcher Awards” due to his extensive contributions to the fields of chemistry and health sciences. His designation as a top researcher at the University of KwaZulu-Natal is a reflection of his innovative approach to drug design and molecular modeling, which has had a profound impact on the scientific community. Prof. Kruger’s work on metallo-beta-lactamase inhibitors, particularly the successful patent that is currently under consideration for clinical trials, demonstrates his ability to translate research into tangible health solutions.

🎓Education:

Prof. Hendrik Gerhardus Kruger obtained his PhD in Chemistry from Potchefstroom University, South Africa. His academic journey laid a strong foundation in organic chemistry, enabling him to specialize in molecular modeling and drug design. Throughout his educational career, he has continually sought to expand his knowledge and expertise, attending various workshops and conferences both nationally and internationally. His commitment to education extends beyond his own studies, as he has actively participated in mentoring students and developing curricula at the University of KwaZulu-Natal. His academic rigor and dedication to advancing chemical sciences have established him as a respected educator and researcher, contributing to the academic landscape in South Africa and beyond. Prof. Kruger’s comprehensive understanding of chemistry and its applications has driven his research endeavors and shaped his contributions to health sciences and drug development.

🏢Work Experience:

Prof. Hendrik Gerhardus Kruger boasts extensive experience in the field of chemistry, particularly in health sciences and drug design. As a Research Professor at the University of KwaZulu-Natal, he has led various research initiatives that emphasize rational drug design and biochemical analysis. Over the years, he has published more than 400 scientific papers and supervised over 100 postgraduate students and 30 postdoctoral fellows, reflecting his commitment to fostering the next generation of scientists. His leadership roles include serving on editorial boards for several reputable journals, including the South African Journal of Chemistry, where he has contributed to the advancement of organic chemistry. Kruger’s experience is further highlighted by his active involvement in industry collaborations, focusing on the development of innovative therapeutic solutions. His holistic approach to research, combining academic rigor with practical applications, has solidified his reputation as a leading figure in his field.

🏅Awards:

Prof. Hendrik Gerhardus Kruger has received numerous accolades for his outstanding contributions to the field of chemistry and health sciences. He is recognized as a top researcher at the University of KwaZulu-Natal, where his innovative work in drug design and molecular modeling has garnered significant attention. As a Fellow of the South African Chemical Institute (SACI), he has been acknowledged for his leadership and influence within the chemical community. His patent for metallo-beta-lactamase inhibitors, currently considered for clinical trials, is a testament to his impactful research. Kruger’s work has also earned him editorial appointments, where he has shaped the direction of scientific publishing. His recognition extends beyond academia, as he is often invited to speak at international conferences, further highlighting his expertise and commitment to advancing scientific knowledge. These honors reflect his dedication to excellence and his role in elevating the standards of chemical research.

🔬Research Focus:

Prof. Hendrik Gerhardus Kruger’s research focus centers on rational drug design, organic chemistry, and molecular modeling, with a commitment to addressing critical health challenges. His innovative work includes elucidating the mechanism of action of new metallo-beta-lactamase (MBL) inhibitors using advanced computational techniques such as hybrid quantum chemical methods and Umbrella sampling. Kruger is also expanding drug design efforts for second-generation MBL inhibitors and exploring new HIV integrase inhibitors. His research involves RNA analysis of pathogens to identify potential drug targets, aiming to enhance treatment strategies for diseases like tuberculosis (TB). By analyzing cellular processes at different treatment stages, his team seeks to shorten treatment times and improve patient outcomes. His multifaceted approach to drug development, combining fundamental research with practical applications, positions him at the forefront of chemical sciences and emphasizes his dedication to innovative therapeutic solutions.

Publication Top Notes:

  • Title: Green solid-phase peptide synthesis 2. 2-Methyltetrahydrofuran and ethyl acetate for solid-phase peptide synthesis under green conditions
    Citations: 7580
  • Title: Bis-and trisindolylmethanes (BIMs and TIMs)
    Citations: 643
  • Title: Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
    Citations: 420
  • Title: The role of nanotechnology in the treatment of viral infections
    Citations: 388
  • Title: Therapeutic peptides

Marina Vesovic | Pharmaceutical chemistry | Medical Chemistry Award

Prof Dr. Marina Vesovic | Pharmaceutical chemistry | Medical Chemistry Award

Professor at Faculty of Medical Sciences Serbia

Prof. Dr. Marina Vesovic is an Associate Professor in the Department of Pharmacy at the Faculty of Medical Sciences, University of Kragujevac. Elected to her current position in June 2023, she specializes in Pharmaceutical Chemistry. Her research focuses on the synthesis, modeling, and evaluation of organic compounds and metal complexes, particularly in relation to their anti-inflammatory, antioxidant, and cytotoxic activities.

Author Metrics

Scopus Profile

  • Citations: 13 citations across 12 documents
  • h-index: 2 (This index measures both the productivity and citation impact of the researcher’s publications.)

Research Documents and Impact

Number of Documents: 5
Citations by Document: Reflects the impact and relevance of each published work.

Education

Prof. Vesovic’s educational background includes advanced studies in Pharmaceutical Chemistry, which laid the foundation for her expertise and ongoing research in this field. Specific details about her degrees and institutions are not provided, but her role as an associate professor indicates a strong academic background.

Research Focus

Her research centers on medicinal chemistry, pharmaceutical chemistry, and bioinorganic chemistry. She investigates the synthesis and biological activities of organic compounds and metal complexes, focusing on their therapeutic potential and biochemical interactions.

Professional Journey

Prof. Vesovic’s professional journey includes her recent promotion to Associate Professor in 2023, her leadership in various research projects, and her active participation in advancing the field of pharmaceutical chemistry. She has mentored graduate students and contributed to significant research projects in her domain.

Honors & Awards

The bio does not mention specific honors or awards, but Prof. Vesovic’s significant contributions to research and education, including her role in various high-impact projects and publications, highlight her esteemed position in her field.

Publications Noted & Contributions

Prof. Vesovic has published extensively, with 18 articles in M20 category journals, 32 in M30, 10 in M50, and 17 in M60. Her notable contributions include a textbook titled “Pharmaceutical Chemistry 1 – Selected Chapters” and numerous research articles detailing her work on pharmaceutical compounds.

Indomethacin Derivatives as Potential Anticancer Agents – Daybreak of New Epoch

Authors: Gogic, A., Vesovic, M., Nedeljkovic, N., Zdravkovic, N., Zivanovic, A.
Journal: ChemistrySelect, 2024, 9(30), e202402050
Citations: 0
Summary: This article explores the potential of indomethacin derivatives as anticancer agents. It presents a detailed study on the synthesis and evaluation of these derivatives, focusing on their anticancer properties. The research aims to offer new insights into drug development for cancer treatment.

Design of Vonoprazan Pyrazole Derivatives as Potential Reversible Inhibitors of Gastric Proton Pump: An In Silico Molecular Docking Study

Authors: Karović, M., Nikolić, B., Nedeljković, N., Vesović, M., Nikolić, M.
Journal: Acta Facultatis Medicae Naissensis, 2024, 41(1), pp. 53–79
Citations: 0
Summary: This article employs in silico molecular docking to design pyrazole derivatives of vonoprazan as potential reversible inhibitors of the gastric proton pump. It offers a computational approach to drug design, aiming to enhance the efficacy of treatments for gastric acid-related disorders.

Synthesis, Characterization, and Investigation of Anti-Inflammatory and Cytotoxic Activities of Novel Thiourea Derivatives of Naproxen

Authors: Nedeljković, N., Nikolić, M., Čanović, P., Vujić, Z., Dobričić, V.
Journal: Pharmaceutics, 2024, 16(1), 1
Citations: 3
Summary: This paper details the synthesis and characterization of novel thiourea derivatives of naproxen, focusing on their anti-inflammatory and cytotoxic activities. The study provides valuable data on these compounds’ potential therapeutic applications and biological effectiveness.

Investigation of the Interaction Between S-Isoalkyl Derivatives of Thiosalicylic Acid and Human Serum Albumin

Authors: Vesović, M., Jelić, R., Nikolić, M., Kljun, J., Tomović, D.
Journal: Journal of Biomolecular Structure and Dynamics, 2024
Citations: 0
Summary: This research investigates how S-isoalkyl derivatives of thiosalicylic acid interact with human serum albumin. The study highlights the binding specificity and potential implications for drug delivery and design.

Synthesis and Investigation of Anti-Inflammatory Activity of New Thiourea Derivatives of Naproxen

Authors: Nedeljković, N., Dobričić, V., Bošković, J., Vujić, Z., Nikolić, M.
Journal: Pharmaceuticals, 2023, 16(5), 666
Citations: 10
Summary: This article focuses on the synthesis and anti-inflammatory activity of new thiourea derivatives of naproxen. It provides insights into how these new compounds might improve treatment for inflammatory conditions and their potential benefits over existing drugs.

Research Timeline

Ongoing projects include investigations into the synthesis and biological properties of organic and metal complex compounds, with a focus on anti-inflammatory and antioxidant activities. Her recent research efforts span from 2023 to the present, continuing to build on her previous work.

Collaborations and Projects

Prof. Vesovic is involved in several research projects funded by the Ministry of Education, Science, and Technological Development. Her projects include the synthesis and characterization of new drug derivatives, and she is a member of professional societies such as the Serbian Crystallographic Society and the Serbian Society for Immunology, Molecular Oncology, and Regenerative Medicine.

Strengths of Prof. Dr. Marina Vesovic for the Medical Chemistry Award

  1. Research Contributions: Prof. Vesovic’s research focuses on significant areas of pharmaceutical chemistry, including anti-inflammatory, antioxidant, and cytotoxic activities. Her work on indomethacin derivatives, pyrazole derivatives of vonoprazan, and novel thiourea derivatives of naproxen illustrates her commitment to advancing drug development and therapeutic applications.
  2. Publication Record: Her extensive publication record, including articles in high-impact journals like ChemistrySelect and Pharmaceutics, demonstrates a strong and active research presence. Notably, her contributions to understanding drug mechanisms and interactions highlight her expertise.
  3. Innovative Research: Prof. Vesovic’s research employs cutting-edge methods such as in silico molecular docking and detailed biochemical investigations. Her studies into drug interactions with human serum albumin and the development of new drug derivatives show a forward-thinking approach to pharmaceutical chemistry.
  4. Educational and Professional Impact: As an Associate Professor at the Faculty of Medical Sciences, University of Kragujevac, Prof. Vesovic plays a vital role in educating the next generation of pharmaceutical chemists. Her leadership in research projects and mentorship of graduate students underscores her influence in the field.
  5. Active Research Projects: Her ongoing research projects funded by reputable organizations and her involvement in professional societies demonstrate her dedication and engagement with the broader scientific community. These efforts contribute to both theoretical and practical advancements in pharmaceutical chemistry.

Areas for Improvement

  1. Citation Impact: Despite a solid publication record, Prof. Vesovic’s citation metrics are relatively modest. Increasing the visibility and impact of her research could involve strategic collaborations and high-profile publications to enhance citation counts.
  2. Research Visibility: While her research is highly relevant, increasing its visibility through conference presentations, media engagement, or collaborative projects with international researchers could further elevate her profile in the field.
  3. Grant Funding: Securing additional research funding or collaborating on larger, multi-institutional grants could provide more resources for her projects and expand the scope of her research.
  4. Publication Diversity: Expanding the range of journals where her work is published, including higher-impact journals or interdisciplinary platforms, might improve both the reach and influence of her research.
  5. Award and Recognition: Gaining recognition through prestigious awards or honors could further validate her contributions to the field. Actively pursuing such accolades or nominations could enhance her professional standing.

Conclusion

Prof. Dr. Marina Vesovic is a promising candidate for the Medical Chemistry Award due to her significant research contributions, extensive publication record, and innovative approaches to drug development. Her work demonstrates a deep understanding of pharmaceutical chemistry and its applications in medicine. By addressing areas such as increasing research visibility and enhancing citation impact, she could further strengthen her candidacy and contribute even more significantly to the field of pharmaceutical chemistry.